Rituximab in ankylosing spondylitis: a promising option when other treatments are not viable

Basit Öğe Kaydı
dc.authoridBulut Gokten, Dilara/0000-0002-9226-7532
dc.contributor.authorGokten, D. BuluT
dc.contributor.authorMercan, R.
dc.date.accessioned2025-04-06T12:23:58Z
dc.date.available2025-04-06T12:23:58Z
dc.date.issued2025
dc.departmentTekirdağ Namık Kemal Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpage549
dc.identifier.issn0392-856X
dc.identifier.issn1593-098X
dc.identifier.issue3
dc.identifier.pmid39625821
dc.identifier.scopus2-s2.0-105000234369
dc.identifier.scopusqualityQ2
dc.identifier.startpage548
dc.identifier.urihttps://hdl.handle.net/20.500.11776/17286
dc.identifier.volume43
dc.identifier.wosWOS:001445365700022
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherClinical & Exper Rheumatology
dc.relation.ispartofClinical and Experimental Rheumatology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250406
dc.subjectTherapy
dc.subjectPatient
dc.titleRituximab in ankylosing spondylitis: a promising option when other treatments are not viable
dc.typeLetter

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu